KerraLite® Cool is a soothing, debriding, moisture balancing dressing for lightly exuding wounds.
• Formulated and designed specifically to encourage wound bed preparation and granulation of chronic wounds, while minimizing pain levels
• Helps to provide an environment for optimal wound healing by managing wound exudate levels and protecting against wound dehydration and external bacterial contamination
• Gel provides both cushioning and absorption
• Partially-hydrated nature of the dressing aids the process of autolytic debridement and helps soothe the wound on contact
Under the supervision of a health care professional, KerraLite® Cool may be used for the management of chronic wounds, on painful wounds and skin conditions such as leg ulcers, radiation therapy damage, burns and scalds.
It may be used on low-exuding and non-exuding wounds to assist in autolytic debridement by hydration of necrotic and sloughy tissue and for absorption of exudate. It may be used on moderately exuding wounds, although in such cases it may be preferable to cut the dressing to fit within the wound margins. The dressing can be used on contaminated and colonized wounds. It may be used with secondary dressings where
appropriate. KerraLite® Cool can be used under compression.
KerraLite® Cool is not indicated for full-thickness wounds, heavily bleeding wounds, third-degree burns or as a covering for deep, narrow cavities or sinuses.
|Antimicrobial format available|
|Bacteria or fluid barrier||●|
|Compatible w/ topicals|
|Conforms readily to wound||●|
|Impermeable to outside contaminants||●|
|Intact when saturated||●|
|Moisture vapor permeable||●|
|Secondary dressing required|
|Usable on infected wounds||●|
|Variety of sizes||●|
|Educational Material Available|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Non/Minimally Exudating Wounds
Acelity leverages the strengths of Kinetic Concepts and Systagenix Wound Management to provide a trusted and complementary portfolio of advanced wound therapeutics for customers and patients in more than 90 countries worldwide.